National Health Insurance Bureau: all localities should include nucleic acid testing and other items in the medical insurance according to the procedures

category:Hot
 National Health Insurance Bureau: all localities should include nucleic acid testing and other items in the medical insurance according to the procedures


uff081uff09 Open online procurement is generally carried out. All local pharmaceutical centralized purchasing agencies should do a good job in the new crown virus detection reagent network, and improve the information sharing and price linkage mechanism between provincial centralized purchasing platforms. Public medical institutions shall purchase new coronavirus detection reagents from the provincial centralized procurement platform of drug consumables in the province.

uff082uff09 Encourage centralized procurement. Encourage provincial and overall regional medical insurance departments to actively explore the centralized procurement of new coronavirus detection reagents, select enterprises with high product quality, strong production capacity, stable supply and good faith, and promote the price return to a reasonable level through competition. In principle, the centralized procurement of new coronavirus detection reagents should be selected from multiple companies to ensure the supply stability. For areas with large-scale population testing needs, priority should be given to centralized procurement. Regions with conditions actively carry out centralized procurement with volume.

2u3001 Improve the price policy of testing items

uff081uff09 The test items are not set up according to the disease. In principle, no distinction shall be made between pathogens or new price items for nucleic acid and antibody detection shall be set up in operation procedures; for class A infectious diseases or related inspection for infectious diseases under class a management according to law, if the risk is difficult and the protection requirements are high, a unified policy for additional charges can be formulated based on the prevailing price items. Public medical institutions carry out nucleic acid and antibody detection for new coronavirus, which can directly implement the existing charging policy without applying for new price items.

uff082uff09 Separate temporary projects need to reflect technology consumption separation. If it is really necessary to set up a single temporary project to meet the demand of new coronavirus detection fees in public medical institutions, local governments are encouraged to set up projects in the way of technology consumption separation. The samples of nucleic acid and antibody detection, such as collection, processing, labeling, recovery, issuance of diagnostic results, and consumables such as nasopharynx swabs, should be combined as the price item of medical service; the in vitro diagnostic kit should be charged at the zero difference rate in addition to the price item of medical service.

3u3001 Do a good job in medical insurance payment

To novel coronavirus pneumonia prevention and control needs, and the payment ability of the local medical insurance fund, we should take the nucleic acid, antibody detection items and related consumables into the provincial medical insurance treatment project catalogue according to the procedures, and determine the payment conditions simultaneously.

Local medical insurance departments should attach great importance to this work. In case of major problems and situations in the work, please report to the State Medical Insurance Bureau in time.